Bbr Partners, LLC Pfizer Inc Transaction History

Bbr Partners, LLC

$1.3 Billion
Q3 2024

A detailed history of Bbr Partners, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Bbr Partners, LLC holds 41,519 shares of PFE stock, worth $1.11 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

41,519

Previous 42,024 1.2%

Holding current value

$1.11 Million

Previous $1.18 Million 2.21%

% of portfolio

0.09%

Previous 0.1%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$27.7 - $31.39 $13,988 - $15,851	-505 Reduced 1.2%	41,519 $1.2 Million
Q2 2024 Aug 05, 2024	SELL	$25.26 - $29.6 $32,787 - $38,420	-1,298 Reduced 3.0%	42,024 $1.18 Million
Q1 2024 May 13, 2024	BUY	$25.89 - $29.73 $7,663 - $8,800	296 Added 0.69%	43,322 $1.2 Million
Q4 2023 Feb 12, 2024	SELL	$26.13 - $33.94 $15,338 - $19,922	-587 Reduced 1.35%	43,026 $1.24 Million
Q3 2023 Nov 13, 2023	BUY	$32.09 - $37.51 $28,431 - $33,233	886 Added 2.07%	43,613 $1.45 Million
Q2 2023 Aug 08, 2023	BUY	$36.12 - $41.79 $1,986 - $2,298	55 Added 0.13%	42,727 $1.57 Million
Q1 2023 May 11, 2023	BUY	$39.39 - $51.28 $31,630 - $41,177	803 Added 1.92%	42,672 $1.74 Million
Q4 2022 Feb 10, 2023	BUY	$41.75 - $54.5 $14,320 - $18,693	343 Added 0.83%	41,869 $2.15 Million
Q3 2022 Nov 10, 2022	SELL	$43.76 - $53.42 $426,266 - $520,364	-9,741 Reduced 19.0%	41,526 $1.82 Million
Q2 2022 Aug 12, 2022	BUY	$46.53 - $55.17 $69,795 - $82,755	1,500 Added 3.01%	51,267 $2.69 Million
Q1 2022 May 16, 2022	BUY	$45.75 - $56.69 $755,607 - $936,292	16,516 Added 49.67%	49,767 $2.58 Million
Q4 2021 Feb 08, 2022	BUY	$41.32 - $61.25 $12,643 - $18,742	306 Added 0.93%	33,251 $1.96 Million
Q3 2021 Nov 12, 2021	SELL	$39.25 - $50.42 $50,122 - $64,386	-1,277 Reduced 3.73%	32,945 $1.42 Million
Q2 2021 Aug 13, 2021	SELL	$35.91 - $40.68 $284,155 - $321,900	-7,913 Reduced 18.78%	34,222 $1.34 Million
Q1 2021 May 17, 2021	BUY	$33.49 - $37.77 $97,054 - $109,457	2,898 Added 7.39%	42,135 $1.53 Million
Q4 2020 Feb 16, 2021	BUY	$33.47 - $42.56 $6,827 - $8,682	204 Added 0.52%	39,237 $1.44 Million
Q3 2020 Nov 12, 2020	BUY	$31.75 - $37.25 $271,176 - $318,152	8,541 Added 28.01%	39,033 $1.43 Million
Q2 2020 Aug 11, 2020	SELL	$30.12 - $36.54 $477,070 - $578,757	-15,839 Reduced 34.19%	30,492 $997,000
Q1 2020 May 14, 2020	SELL	$27.03 - $38.62 $402,017 - $574,395	-14,873 Reduced 24.3%	46,331 $1.51 Million
Q4 2019 Feb 14, 2020	BUY	$32.92 - $37.36 $489,586 - $555,617	14,872 Added 32.1%	61,204 $2.4 Million
Q3 2019 Nov 12, 2019	BUY	$32.49 - $42.13 $3,476 - $4,507	107 Added 0.23%	46,332 $1.67 Million
Q2 2019 Aug 14, 2019	SELL	$36.98 - $41.52 $52,104 - $58,501	-1,409 Reduced 2.96%	46,225 $2 Million
Q1 2019 May 10, 2019	BUY	$37.5 - $41.2 $268,537 - $295,033	7,161 Added 17.69%	47,634 $2.02 Million
Q4 2018 Feb 08, 2019	BUY	$38.47 - $43.86 $168,229 - $191,799	4,373 Added 12.11%	40,473 $1.77 Million
Q2 2018 Aug 14, 2018	BUY	$32.98 - $35.16 $391,142 - $416,997	11,860 Added 48.93%	36,100 $1.31 Million
Q1 2018 May 10, 2018	BUY	$31.91 - $37.02 $773,498 - $897,364	24,240 New	24,240 $860,000

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bbr Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bbr Partners, LLC with notifications on news.

Account